COVID-19 funding announcement
CREID are directing almost $300,000 in research funding to tackle the emergence of COVID-19 through applying previously allocated, internal grant and contingency funds. By joining forces with APPRISE, a total of over $700,000 has been made available for research into SARS-CoV-2 and COVID-19.
- Deep sequencing to better understand the dynamics of within-host viral diversity during prolonged, severe SARS-CoV-2 infection – John-Sebastian Eden
- Diagnosis of COVID-19 (evaluation of nucleic acid testing and viral culture, in-house and commercial) – Jen Kok, David Smith, John-Sebastian Eden (co-funded by APPRISE)
- COVID-19 infection prevention & control – Lyn Gilbert, Chris Degeling (co-funded by APPRISE)
- Serology of Australian healthcare workers caring for individuals exposed to or diagnosed with SARS-CoV-2 – Matthew O’Sullivan (co-funded by APPRISE)
- Expanding ICU surveillance for COVID-19 – Allen Cheng, Husna Begum
- Understanding host response of severe viral pneumonitis – Ben Tang (co-funded by APPRISE)
- Community awareness, perceptions and behaviour about COVID-19, its prevention and management: informing risk communication – Julie Leask, Kerrie Wiley, Claire Hooker, Adam Dunn
- Infectious Diseases and “Infodemics” – The Role of Social Media in Individual and Collective Meaning Making – Christian Ehnis, Deborah Bunker
- Biosecurity and biocontainment of high-consequence infections: Principles & practice – Gabriella Scandurra
- The role of bad information and flawed cognition in the spread of disease: the case of COVID-19 – Nick Enfield (co-funded by APPRISE).